Drug Testing Locations in West Virginia

Accredited Drug Testing has 29 drug testing centers in 557 WV cities.

Please select a city from the list below to find drug test centers in West Virginia.

Why West Virginia Employers Rely on Our Drug Testing Services

West Virginia employers face unique challenges in maintaining drug-free workplaces, and that’s why our 152 test centers across 557 cities provide tailored solutions. Our services help mitigate risks, enhance productivity, and ensure compliance with state and federal regulations.

By utilizing our extensive network, employers can implement effective drug policies that deter substance misuse. Our comprehensive testing solutions cover pre-employment screenings, random tests, and post-incident testing, ensuring your workforce remains reliable and safe.

Our advanced technology guarantees precise and confidential results, empowering businesses to make informed hiring and management decisions. This contributes to a reduction in workplace accidents and associated costs, ultimately boosting overall morale and operational efficiency.

In a state where community wellbeing is a priority, our services provide peace of mind to West Virginia employers. Engage with us to uphold stringent safety standards, protect your employees, and foster a culture of responsibility and wellbeing across your organization.

West Virginia Drug Free Workplace Programs

West Virginia acknowledges the vital role of maintaining safety and health in professional environments, especially concerning substance abuse. The state actively promotes initiatives aimed at reducing drug use among workers, recognizing that a clear-minded workforce enhances productivity and safety. Through education and prevention programs, West Virginia seeks to address substance abuse by providing resources and support to businesses, ensuring they are equipped to handle potential drug-related challenges.

These efforts are complemented by community outreach and collaboration with local organizations to emphasize the importance of a drug-free lifestyle. The state prioritizes fostering a supportive atmosphere where employees feel encouraged to seek help if needed. By focusing on these positive steps, West Virginia demonstrates its commitment to creating safer workplaces and healthier communities, emphasizing the well-being and efficient management of its workforce.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Mobile/On-Site Drug Testing

If you're an employer needing to test 25 or more employees and looking to save time and money, we offer mobile on-site drug testing where we come to you. Call us today for more information.

West Virginia Laws on Drugs

In West Virginia, the regulation of controlled substances is governed primarily by Chapter 60A of the West Virginia Code. The laws classify drugs into different schedules based on their potential for abuse, medical use, and safety. Unlawful manufacture, possession, or distribution of controlled substances can result in severe penalties, including imprisonment and fines.

Efforts are ongoing to address the drug epidemic in West Virginia through initiatives focusing on education, prevention, and rehabilitation. Enhanced penalties apply when drug-related offenses involve minors or occur near schools, highlighting the state’s commitment to protecting its communities from the adverse effects of drug misuse.

West Virginia Laws on Marijuana

West Virginia legalized medical cannabis in 2017 with the passage of the Medical Cannabis Act. This allows patients with qualifying conditions, such as chronic pain and epilepsy, to obtain cannabis with a physician's recommendation. However, recreational use remains illegal, and strict regulations govern the possession and use of medical cannabis.

Patients must register with the West Virginia Medical Cannabis Program and obtain an ID card to purchase cannabis from authorized dispensaries. The state continues to develop regulations to ensure secure access for patients while preventing misuse, reflecting a careful approach to balancing therapeutic needs and public safety.

West Virginia Drug Resources

WV DHHR
West Virginia Department of Health and Human Resources site.

DEA Take Back Day
Safe disposal of prescription drugs.

Help & Hope WV
Resources for substance abuse prevention.

Spotify Cares
Support for individuals and families affected by addiction.

NARCAN
Information on overdose response medication.

West Virginia OEMS
Emergency medical services and preparedness resources.

WV Restore
A confidential resource for troubled healthcare professionals.

National Association of State Alcohol and Drug Abuse Directors
Find state-specific support for alcohol and drug issues.

SAMHSA
Substance Abuse and Mental Health Services Administration support.

Drug Testing Near , WV

Frequently Asked Questions

Customer Reviews